Psychedelics conference season is upon us. Out of very large and well-known events to small meetingsthe remaining months of this year are packed with in-person and virtual discussions surrounding the natural herbal and synthetic medicines revolutionizing mental health.
Let’s take a look at some of these that will take place in the coming weeks.
HC Wainwright 24th Annual Global Investment
-
That HC Wainwright 24th Annual Global Investment conference is employed September 12th to 14th. Both virtually and in person at the Lotte New York Palace HotelThe event invites public and private companies, industry and business development executives, institutional investors, private equity firms and venture capitalists to attend and benefit from networking opportunities, investor meetings and company presentations, including big industry names such as Braxia Scientific BRAXF and ATai Life Sciences ATAI.
-
12. Concordia Annual Summit
-
Heads of state, private and NGO sector leaders, and new and diverse perspectives will come together to create concrete solutions to local and global challenges in the 12. Concordia Annual Summit September 19-21 at the Sheraton New York Times Square Hotel.
Concordia is a nonprofit, nonpartisan organization that has been building meaningful partnerships for positive social impact since 2011. This year’s presentations will focus on issues such as substance abuse, addiction, post-traumatic stress disorder, depression, end-of-life anxiety, and other conditions that impact mental health on a global scale, while providing an overview of the past, present, and future of psychedelics policy and science. -
Psilocybin San Francisco
-
Psilocybin San Francisco conference this year will be one Virtual meeting scheduled for September 21st and 22nd to discuss “the A to Z of psilocybin mushrooms.” Topics will include a historical review and future prospects for the drug, the biology of psilocybin, risk and harm reduction, travel planning, preparation and integration, and…
